Related Experiment Video
Updated: Dec 28, 2025

High-throughput Purification of Affinity-tagged Recombinant Proteins
Published on: August 26, 2012
Structural basis for RNA polymerase III transcription repression by Maf1
Matthias K Vorländer1,2, Florence Baudin1, Robyn D Moir3
1Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Maf1 protein inhibits RNA polymerase III (Pol III) transcription. The study reveals Maf1 blocks Pol III initiation by binding key elements, including the C34 domain, and overlaps with TFIIIB binding sites.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- Maf1 is a crucial regulator of RNA polymerase III (Pol III).
- Pol III controls the transcription of essential non-coding RNAs.
- Maf1's role in regulating cellular processes like metabolism and lifespan is known, but its precise mechanism of inhibition is unclear.
Purpose of the Study:
- To elucidate the structural mechanism by which Maf1 inhibits RNA polymerase III (Pol III).
- To provide a high-resolution structure of the Maf1-Pol III complex.
Main Methods:
- Cryo-electron microscopy (cryo-EM) at 3.3-Å resolution.
- Structural analysis of yeast Maf1 bound to Pol III.
Main Results:
- The cryo-EM structure reveals how Maf1 binds to Pol III.
- Maf1 sequesters key Pol III elements essential for transcription initiation.
- Maf1 binds the mobile C34 winged helix 2 domain, effectively sealing the active site.
- The Maf1 binding site significantly overlaps with the binding site of TFIIIB, a transcription initiation factor.
Conclusions:
- Maf1 inhibits Pol III transcription by physically blocking the active site and interfering with initiation factor binding.
- This structural insight clarifies Maf1's role as a conserved inhibitor of Pol III.
- Understanding Maf1-Pol III interaction may offer new avenues for targeting Pol III-dependent processes.
Related Concept Videos
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Master Transcription Regulators
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

